We are live on ! Find out more
AICPI

ABG Innovation Capital Partners III Portfolio holdings

AUM $64.5K
1-Year Est. Return 1.01%
This Fund
S&P 500
This Quarter Est. Return
-12.2%
1 Year Est. Return
+1.01%
3 Year Est. Return
+5.56%
5 Year Est. Return
-85.52%
10 Year Est. Return
AUM
$1.09M
AUM Growth
-$223K
Cap. Flow
-$19.7K
Cap. Flow %
-1.81%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ACGN
Aceragen Inc
ACGN
+$19.7K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSTL icon
1
Castle Biosciences
CSTL
$929M
$764K 70.27%
33,626
WHWK
2
Whitehawk Therapeutics
WHWK
$201M
$193K 17.76%
26,666
SYBX
3
DELISTED
Synlogic
SYBX
$130K 11.97%
13,727
ACGN
4
DELISTED
Aceragen Inc
ACGN
-3,309
Closed -$19.7K

Similar funds

ABG Innovation Capital Partners III's Q1 2023 Portfolio in Review

As of Q1 2023, ABG Innovation Capital Partners III held 4 positions worth $1.09M, down 17% from $1.31M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

ABG Innovation Capital Partners III's Q1 2023 filing shows 1 closed position. The largest sale was Aceragen Inc, an estimated $19.7K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • ABG Innovation Capital Partners III fully exited Aceragen Inc in Q1 2023, selling an estimated $19.7K.
  • ABG Innovation Capital Partners III's ten largest holdings make up 100% of its $1.09M portfolio in Q1 2023.
  • ABG Innovation Capital Partners III opened 0 new positions and closed 1 in Q1 2023.
  • ABG Innovation Capital Partners III's portfolio value fell 17% quarter-over-quarter to $1.09M.

Based on ABG Innovation Capital Partners III's 13F filing for Q1 2023, filed 15 May 2023.